论文部分内容阅读
目的探讨卡前列素氨丁三醇联合宫腔Bakri球囊填塞用于治疗型前置胎盘的效果。方法选取2014年1月至2017年1月东莞市长安医院收治的32例凶险型前置胎盘患者作为研究对象,按照随机数字表法将其分为对照组与观察组,各16例。对照组患者采用卡前列素氨丁三醇治疗,观察组患者实施卡前列素氨丁三醇联合宫腔Bakri球囊填塞治疗,比较两组患者的临床效果。结果观察组患者不良反应发生率明显低于对照组,差异有统计学意义(P<0.05);观察组患者剖宫产术中出血量、术后24 h出血量均明显少于对照组,恶露持续时间明显短于对照组,差异均有统计学意义(均P<0.05);观察组患者治疗的总有效率为93.8%,明显高于对照组的68.8%,差异有统计学意义(P<0.05)。结论卡前列素氨丁三醇联合宫腔Bakri球囊填塞用于治疗凶险型前置胎盘具有显著效果,能有效控制出血量,且安全性较高。
Objective To investigate the effect of cardiotomycin trometamol combined with intrauterine Bakri balloon tamponade on therapeutic placenta previa. Methods From January 2014 to January 2017, 32 cases of dangerous placenta previa were enrolled in Chang’an Hospital of Dongguan City. The patients were divided into control group and observation group according to random number table. Patients in the control group were treated with carboprost trometamol. Patients in the observation group were treated with carboprost trometamol and uterine Bakri balloon tamponade. The clinical effects of the two groups were compared. Results The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P <0.05). The bleeding volume in the cesarean section and the blood loss at 24 hours after operation in the observation group were significantly less than those in the control group and lochia The duration was significantly shorter than the control group, the difference was statistically significant (all P <0.05); the total effective rate of treatment group was 93.8%, significantly higher than 68.8% of the control group, the difference was statistically significant (P < 0.05). Conclusion The combination of carboprost trometamol and uterine cavity Bakri balloon capsule has significant effect on the treatment of dangerous placenta previa. It can effectively control the amount of bleeding and has higher safety.